EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/18/2025
Back to search
Official data from USPTO
MUCINEX SINUS-MAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
02/18/2025
Trademark type
Combined
Nice classes
5
Filing date
11/01/2022
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/31/2016
First use in commerce
01/31/2016
Drawing code
3
Owner type
16
Owner location
Parsippany, NJ
Examiner
MCCARTHY, BRIDGET
Current location
Historical data usage
Mark description
The mark consists of a red bar in the upper left corner of a white background. In the center of the top half of the field is the stylized word "MUCINEX" in blue on above the stylized words "SINUS-MAX" in white within a red background, all of which is surrounded by a grey outline. In the center below the wording is gray arc that tapers at the edges. A red tablet design appears to its left with light rays emanating from the bottom of the tablet in white. The tablet rests at the top of a solid and dotted orange field. On each side is an elongated gray arc.
Holders and representatives
Holders
RB Health (US) LLC
Representatives
Mark Lerner, Esq. DUANE MORRIS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; decongestants; Pharmaceutical antitussive-cold preparations; Preparations for treating colds
Publications
History of USPTO decisions and trademark events.
15 publications found
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
02/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/21/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/23/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2023
DOCK
ASSIGNED TO EXAMINER
06/21/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2022
NWAP
NEW APPLICATION ENTERED
11/04/2022
Continuous trademark protection
Get notified about every new filing that threatens MUCINEX SINUS-MAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.